Craft

Hemogenyx Pharmaceuticals

Stock Price

£0

2024-05-02

Market Capitalization

£21 M

2024-05-02

Hemogenyx Pharmaceuticals Summary

Company Summary

Overview
Hemogenyx Pharmaceuticals, formerly Silver Falcon, is a pre-clinical stage biopharmaceutical company. It is engaged in bone marrow transplantation. The Company develops medicines and treatments to handle blood diseases. 
Type
Public
Status
Active
Founded
2013
HQ
London, GB | view all locations
Website
http://silverfalconplc.com/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • London, England HQ

    United Kingdom

    5 Fleet Place

Hemogenyx Pharmaceuticals Financials

Summary Financials

Net income (H1, 2023)
(£4.3M)
Cash (H1, 2023)
£3.1M
EBIT (H1, 2023)
(£4.4M)
Enterprise value
$21.2M

Footer menu